Oscar Health, Inc. (OSCR) Stock
OSCR has an Alpha Score of 56 out of 100 (moderate), computed on Aug 23, 2026 from 2 of 4 sub-scores. 7 of the hedge funds AlphaScala tracks reported OSCR in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is D.E. Shaw's at $360.60M. Company insiders reported 0 open-market buys and 9 sales on SEC Form 4 in the 90 days to Oct 21, 2026. Its trailing P/E ratio is 18.4 and its net margin 3.6% (key statistics as of Oct 21, 2026).
What is OSCR's Alpha Score?
How it works →Alpha Score of 56 reflects moderate overall profile with strong momentum, weak quality. Based on 2 of 4 signals – score is capped at 75 until remaining data ingests.
Computed from 2 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.
Computed Aug 23, 2026 · 60 days ago; due for a rescore
A rules-based research rating, not a recommendation to buy or sell.
Which hedge funds own OSCR?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| D.E. Shaw David Shaw | 12.64M | $360.60M | +131% |
| Citadel Ken Griffin | 4.23M | $120.63M | +22% |
| Renaissance Technologies Jim Simons (founder) | 3.28M | $93.67M | NEW |
| Point72 Steve Cohen | 800K | $22.81M | -74% |
| Millennium Management Israel Englander | 641K | $18.29M | +55% |
| Marshall Wace | 598K | $17.06M | -35% |
| Bridgewater Associates Ray Dalio | 214K | $6.09M | NEW |
13F holdings as of Jun 30, 2026
Explore all tracked funds →Are Oscar Health, Inc. insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Sep 18, 26 | Wittman Vanessa Ames | Director | SELL | 25.0K | $806K |
| Sep 3, 26 | Blackley Richard Scott | Chief Financial Officer | SELL | 28.9K | $908K |
| Sep 3, 26 | Liang Janet | President, Oscar Insurance | SELL | 10.4K | $326K |
| Sep 3, 26 | Mcananey Adam | Chief Legal Officer | SELL | 9.1K | $286K |
| Sep 3, 26 | Schlosser Mario | Director | SELL | 31.4K | $988K |
| Sep 3, 26 | Baltrus Victoria | Chief Accounting Officer | SELL | 958 | $30K |
| Aug 28, 26 | Schlosser Mario | Director | SELL | 150.0K | $4.6M |
| Aug 27, 26 | Schlosser Mario | Director | SELL | 600.0K | $18.2M |
| Aug 18, 26 | Blackley Richard Scott | Chief Financial Officer | SELL | 18.8K | $595K |
SEC Form 4 filings as of Oct 21, 2026
See cluster-buy signals across all tickers →What are OSCR's key statistics?
Key statistics as of Oct 21, 2026
How does OSCR's valuation compare with the Healthcare sector?
| Metric | OSCR | Healthcare median | Companies in median |
|---|---|---|---|
| P/E ratio | 18.4 | 27.0 | 75 |
| Net margin | 3.60% | 9.40% | 92 |
| Return on equity | 38.53% | 11.24% | 99 |
Medians over the Healthcare stocks whose key statistics were refreshed in the last 35 days (newest Oct 22, 2026). P/E excludes loss-making companies.
OSCR price chart
Powered by TradingViewWhat does Oscar Health, Inc. do?
Oscar Health, Inc. is a technology-driven health insurance company headquartered in New York, New York. It delivers health plans to individuals, families, employees, and small groups through a proprietary digital platform that simplifies enrollment, claims processing, and member support. The company offers on-exchange and off-exchange individual and family medical plans compliant with the Affordable Care Act, alongside small group coverage and Medicare Advantage options. Oscar Health, Inc. also provides its technology platform to other providers and payers in the healthcare ecosystem, enabling efficient operations and enhanced user experiences. By integrating advanced tools like agentic AI, it focuses on operational efficiencies and member-centric services in the managed health care sector. Founded in 2012, Oscar Health, Inc. plays a key role in modernizing health insurance delivery for diverse markets across the United States.